Physician

Anthony C Ingenito, MD

According to 2025 Medicare claims, Anthony Ingenito, MD (NPI: 1710940127) practices radiation oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 07601-5419. Ingenito is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Ingenito's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 368 traditional Medicare patients, billed 3,298 HCPCS/CPT codes, and received $501,705 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 31 prescription claims across 22 beneficiaries totaling $587 in drug costs, led by Silver Sulfadiazine (Silver Sulfadiazine). 2017 DME data shows 12 claims. Open Payments data shows 2 records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $942,105 to $501,705. Similarly, Part D prescription costs have declined steadily, from $1,828 to $587. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.